{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:59:48Z","timestamp":1769137188358,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dld.2025.12.018","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T12:10:01Z","timestamp":1767442201000},"page":"241-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatments"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1968-9517","authenticated-orcid":false,"given":"Lorenzo","family":"Canova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-6504","authenticated-orcid":false,"given":"Massimo","family":"Iavarone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Alimenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-4854","authenticated-orcid":false,"given":"Mariangela","family":"Bruccoleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Argiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Perbellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-4744","authenticated-orcid":false,"given":"Floriana","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Uceda Renteria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Degasperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Ierardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sangiovanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-7502","authenticated-orcid":false,"given":"Matteo","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Lampertico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2025.12.018_bib0002","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.dld.2025.12.018_bib0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"81","key":"10.1016\/j.dld.2025.12.018_bib0004","first-page":"197","article-title":"Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC)","volume":"55","author":"Murakami","year":"2008","journal-title":"Hepatogastroenterology"},{"issue":"12","key":"10.1016\/j.dld.2025.12.018_bib0005","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/cncr.11839","article-title":"The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma","volume":"98","author":"Nagaoka","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0006","first-page":"22","article-title":"Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-\u03b3-carboxyprothrombin","volume":"31","author":"Inagaki","year":"2011","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"28","key":"10.1016\/j.dld.2025.12.018_bib0007","first-page":"2464","article-title":"Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma","volume":"46","author":"Tanaka","year":"1999","journal-title":"Hepatogastroenterology"},{"issue":"10","key":"10.1016\/j.dld.2025.12.018_bib0008","doi-asserted-by":"crossref","first-page":"e0262","DOI":"10.1097\/HC9.0000000000000262","article-title":"GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study","volume":"7","author":"Villa","year":"2023","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.dld.2025.12.018_bib0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.32185","article-title":"GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis","volume":"75","author":"Singal","year":"2022","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.dld.2025.12.018_bib0010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2025.12.018_bib0011","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/gutjnl-2018-316525","article-title":"A simple AGED score for risk classification of primary liver cancer: development and validation with long-term prospective HBsAg-positive cohorts in Qidong","volume":"68","author":"Fan","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2023.09.011","article-title":"PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B","volume":"80","author":"Chun","year":"2024","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.dld.2025.12.018_bib0013","doi-asserted-by":"crossref","first-page":"e0317","DOI":"10.1097\/HC9.0000000000000317","article-title":"Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies","volume":"7","author":"Piratvisuth","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0014","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.dld.2025.12.018_bib0015","doi-asserted-by":"crossref","first-page":"e0264","DOI":"10.1097\/HC9.0000000000000264","article-title":"Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe","volume":"7","author":"Beudeker","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2025.12.018_bib0016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/tgh.2019.06.07","article-title":"Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong","volume":"4","author":"Chan","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.12.018_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.12659\/AOT.894644","article-title":"Relevance of pre-transplant \u03b1-fetoprotein dynamics in liver transplantation for hepatocellular cancer","volume":"21","author":"Gr\u0105t","year":"2016","journal-title":"Ann Transplant"},{"issue":"7","key":"10.1016\/j.dld.2025.12.018_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13634","article-title":"Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality","volume":"33","author":"Mahmud","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.dld.2025.12.018_bib0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0039-1677768","article-title":"Alpha-fetoprotein for diagnosis, prognosis, and transplant selection","volume":"39","author":"Trevisani","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2025.12.018_bib0020","article-title":"Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China","volume":"12","author":"Hou","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.dld.2025.12.018_bib0021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jhep.2014.11.005","article-title":"Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion","volume":"62","author":"Pot\u00e9","year":"2015","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2025.12.018_bib0022","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00268-013-1966-0","article-title":"Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma","volume":"37","author":"Kim","year":"2013","journal-title":"World J Surg"},{"issue":"22","key":"10.1016\/j.dld.2025.12.018_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216485","article-title":"Galad score as a prognostic marker for patients with hepatocellular carcinoma","volume":"24","author":"Cagnin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.dld.2025.12.018_bib0024","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2019.01.013","article-title":"Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study","volume":"70","author":"Wang","year":"2019","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2025.12.018_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1159\/000530987","article-title":"Usefulness of aMAP risk score for predicting recurrence after curative treatment for hepatocellular carcinoma within Milan criteria","volume":"101","author":"Ohama","year":"2023","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.dld.2025.12.018_bib0026","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2025.12.018_bib0027","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","article-title":"Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept","volume":"24","author":"Vitale","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10415","key":"10.1016\/j.dld.2025.12.018_bib0028","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.dld.2025.12.018_bib0029","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2024.01.018","article-title":"Navigating the landscape of liver cancer management: study designs in clinical trials and clinical practice","volume":"80","author":"Cabibbo","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2025.12.018_bib0030","doi-asserted-by":"crossref","first-page":"45263","DOI":"10.21037\/hbsn-20-480","article-title":"2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights","volume":"9","author":"Xie","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0031","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.dld.2025.12.018_bib0032","first-page":"1987","article-title":"The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy","volume":"40","author":"Loglio","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"3","key":"10.1016\/j.dld.2025.12.018_bib0033","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/apt.16685","article-title":"Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents","volume":"55","author":"Degasperi","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.12.018_bib0034","unstructured":"Diagnostics A. PIVKA-II 2P48 [Package Insert] F5\u2013Y309-2; 2015."},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00268-019-05206-5","article-title":"Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma","volume":"44","author":"Toshima","year":"2020","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.dld.2025.12.018_bib0036","doi-asserted-by":"crossref","first-page":"93","DOI":"10.17998\/jlc.2022.03.28","article-title":"Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma","volume":"22","author":"Kim","year":"2022","journal-title":"J Liver Cancer"},{"issue":"2","key":"10.1016\/j.dld.2025.12.018_bib0037","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2025.12.018_bib0038","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s12072-022-10348-1","article-title":"Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies","volume":"16","author":"Fu","year":"2022","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.dld.2025.12.018_bib0039","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SLA.0000000000006386","article-title":"Tumor mutational burden from circulating Tumor DNA predicts recurrence of hepatocellular carcinoma after resection: an emerging biomarker for surveillance","volume":"280","author":"Wehrle","year":"2024","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.dld.2025.12.018_bib0040","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2024-331956","article-title":"Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments","volume":"73","author":"Campani","year":"2024","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.dld.2025.12.018_bib0041","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/gtmb.2022.0032","article-title":"Predictive value of the TP53 p.G245S mutation frequency for the short-term recurrence of hepatocellular carcinoma as detected by pyrophosphate sequencing","volume":"26","author":"Yu","year":"2022","journal-title":"Genet Test Mol Biomark"},{"key":"10.1016\/j.dld.2025.12.018_bib0042","first-page":"269","article-title":"TSC2 Mutations were associated with the early recurrence of patients with HCC underwent hepatectomy","volume":"14","author":"Song","year":"2021","journal-title":"Pharmacogenomics Pers Med"},{"issue":"4","key":"10.1016\/j.dld.2025.12.018_bib0043","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/v14040775","article-title":"Alpha-fetoprotein (AFP) and AFP-L3 is most useful in detection of recurrence of hepatocellular carcinoma in patients after tumor ablation and with low AFP level","volume":"14","author":"Force","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.dld.2025.12.018_bib0044","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00535-010-0278-5","article-title":"AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC","volume":"45","author":"Yamamoto","year":"2010","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2025.12.018_bib0045","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/cancers15051551","article-title":"AFP response to locoregional therapy can stratify the risk of tumor recurrence in HCC patients after living donor liver transplantation","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.dld.2025.12.018_bib0046","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.12.018_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.876668","article-title":"Splenic volume, an easy-to-use predictor of HCC late recurrence for HCC patients after hepatectomy","volume":"12","author":"Fang","year":"2022","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.dld.2025.12.018_bib0048","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1007\/s00330-020-06792-y","article-title":"Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment","volume":"30","author":"Cho","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24823","article-title":"Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma","volume":"37","author":"Tian","year":"2023","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","article-title":"PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma","volume":"21","author":"Feng","year":"2021","journal-title":"BMC Cancer"},{"issue":"43","key":"10.1016\/j.dld.2025.12.018_bib0051","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027673","article-title":"AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.dld.2025.12.018_bib0052","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1007\/s10620-010-1177-6","article-title":"HCC in older patients","volume":"55","author":"Carr","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.dld.2025.12.018_bib0053","first-page":"208","article-title":"Significant impact of patient age on outcome after liver resection for HCC in cirrhosis","volume":"40","author":"Faber","year":"2014","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5582\/bst.2020.03437","article-title":"Impact of patient age on outcome after resection for hepatocellular carcinoma","volume":"15","author":"Harada","year":"2021","journal-title":"Biosci Trends"},{"key":"10.1016\/j.dld.2025.12.018_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106843","article-title":"Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study","volume":"105","author":"Wang","year":"2022","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.dld.2025.12.018_bib0056","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/02656736.2020.1778198","article-title":"Prognosis of microwave ablation for hepatocellular carcinoma: does age make a difference?","volume":"37","author":"Zhang","year":"2020","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group"},{"issue":"6","key":"10.1016\/j.dld.2025.12.018_bib0057","first-page":"1339","article-title":"Effect of age on the short- and long-term outcomes of patients undergoing curative liver resection for HCC","volume":"48","author":"Tan","year":"2022","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"5","key":"10.1016\/j.dld.2025.12.018_bib0058","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MEG.0000000000002745","article-title":"Prognostic analysis of sex and age in hepatocellular carcinoma: a SEER study","volume":"36","author":"Chen","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.dld.2025.12.018_bib0059","doi-asserted-by":"crossref","first-page":"17866","DOI":"10.1002\/cam4.6422","article-title":"Effect of PIVKA-II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery","volume":"12","author":"Cai","year":"2023","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.dld.2025.12.018_bib0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/MEG.0b013e3283535c34","article-title":"Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels","volume":"24","author":"Kang","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.dld.2025.12.018_bib0061","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.7314\/APJCP.2014.15.16.6673","article-title":"Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:33:04Z","timestamp":1769085184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825012563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1590865825012563"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.12.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatments","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}